Viewing Study NCT01573533


Ignite Creation Date: 2025-12-25 @ 2:40 AM
Ignite Modification Date: 2026-03-01 @ 8:55 PM
Study NCT ID: NCT01573533
Status: COMPLETED
Last Update Posted: 2020-02-10
First Post: 2012-04-05
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Pilot Study to Assess the Efficacy of Rituximab Therapy in Treatment Resistant FSGS
Sponsor: Mayo Clinic
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 12-005640
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View
None NIH View
None INDUSTRY View
None OTHER View
None NIH View